Google

AHA, Verily, AstraZeneca announce One Brave Idea Research Award Winner

Tuesday, October 11, 2016

The American Heart Association (AHA), Verily Life Sciences (formerly Google Life Sciences), an Alphabet company, and AstraZeneca, have announced that the One Brave Idea research award will be granted to Dr. Calum MacRae, chief of Cardiovascular Medicine at Boston’s Brigham and Women’s Hospital, to support his visionary approach to understanding and addressing coronary heart disease (CHD) and its devastating consequences.

[Read More]

Industry leaders establish partnership on AI best practices

Thursday, September 29, 2016

Amazon, DeepMind/Google, Facebook, IBM and Microsoft will create a nonprofit organization that will work to advance public understanding of artificial intelligence technologies (AI) and formulate best practices on the challenges and opportunities within the field. Academics, non-profits and specialists in policy and ethics will be invited to join the board of the organization, named the Partnership on Artificial Intelligence to Benefit People and Society (Partnership on AI).

[Read More]

Sanofi, Verily Life Sciences launch Onduo for diabetes management platform

Wednesday, September 14, 2016

Sanofi and Verily Life Sciences, (formerly Google Life Sciences), an Alphabet company, have announced the launch of Onduo, a joint venture created through Sanofi and Verily’s diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge. Onduo’s mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management.

[Read More]

GSK and Verily’s Galvani Bioelectronics forges ahead, ushering in a new era of medicine

Monday, August 8, 2016

Galvani Bioelectronics, a newly established company launched by GlaxoSmithKline (GSK) and Verily Life Sciences (formerly Google Life Sciences), will explore a new wave of science. Galvani Bioelectronics will focus on the development of bioelectronic medicine: the use of implantable devices to modify the electrical signals that nerve cells use to communicate within the body.

[Read More]

NIH awards $55M to build million-person precision medicine study

Thursday, July 7, 2016

The NIH has announced $55 million in awards in fiscal year 2016 to build the foundational partnerships and infrastructure needed to launch the Cohort Program of President Obama’s Precision Medicine Initiative (PMI). The PMI Cohort Program is a landmark longitudinal research effort that aims to engage 1 million or more U.S. participants to improve our ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

[Read More]